Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers

Human Psychopharmacology

Volumn 25, Issue 6, 2010, Pages 472-480

  Drueke, Barbara ^a   Boecker, Maren ^a   Schlaegel, Sonja ^a   Moeller, Olaf ^b   Hiemke, Christoph ^c   Gründer, Gerhard ^b,d   Gauggel, Siegfried ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d JARA   (Germany)

Author keywords

5 HT; Escitalopram; Response inhibition; Response re engagement; Stop change task

Indexed keywords

CIPRAPLEX; ESCITALOPRAM; PLACEBO; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SEROTONINERGIC SYSTEM; TASK PERFORMANCE; VOLUNTEER;

ADULT; CITALOPRAM; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; REACTION TIME; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 77956563811     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1141     Document Type: Article

References (53)

1. Aronson S, Delgado P. 2004. Escitalopram. Drugs Today 40(2): 121-131.
2. Burke WJ. 2002. Escitalopram. Expert Opin Investig Drugs 11(10): 1477-1486.
3. Bjork J, Dougherty D, Moeller F, Swann A. 2000. Differential behavioural effects of plasma tryptophan depletion and loading in aggressive and nonaggressive men. Neuropsychopharmacology 22: 357-369.
4. Blier P, de Montigny C. 1999. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21: 91S-98S.
5. Boecker M, Buecheler MM, Schroeter ML, Gauggel S. 2007. Prefrontal brain activation during Stopp-signal response inhibition: an event-related functional near-infrared spectroscopy study. Behav Brain Res 176: 259-266.
6. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. 2005. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neuosci 25: 532-538.
7. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. 2005. The neuropsychology of obsessive compulsive disorder: the importance of failures and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev 29: 399-419.
8. Chamberlain SR, Mueller U, Blackwell AD, Clark l, Robbins TW, Sahakian BJ. 2006. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311: 861-863.
9. Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW. 2005. Stop signal response inhibition is not modulated by tryptophan depletion or serotonergic transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 182: 570-578.
10. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC. 2007. Cognitive Inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. Cereb Cortex 17: 18-27.
11. Cohen J. 1988. Statistical power ananlysis for the behavioral sciences, 2nd edn. Lawrence Earlbaum Associates: Hillsdale.
12. Cools R, Roberts AC, Robbins TW. 2008. Serotonergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12(1): 31-40.
13. Dalley JW, Mar AC, Economidou D, Robbins TW. 2008. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behaviour 90(2): 250-260.
14. Del-Ben CM, Deakin JF, McKie S, et al. 2005. The effect of Citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30: 1724-1734.
15. Drueke B, Baetz J, Boecker M, et al. 2009. Differential effects of escitalopram on attention: a placebo-controlled double-blind, cross-over study. Psychopharmacology (Berl) 10.1007/s00213-009- 1649-6.
16. Eagle DM, Robbins TW. (2003). Inhibitory control in rats performing a stop-signal reaction-time task: Effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117: 1302-1317.
17. Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW. 2008. Stop-signal reaction-time task performance: Role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 18, 178-188.
18. Eagle DM, Bari A, Robbins TW. 2008a. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/nogo tasks. Psychopharmacology (Berl) 199 439-456
19. Eagle DM, Lehmann O, Theobald DE, et al. 2009. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories and the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 34(5): 1311-1321.
20. Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G*Power3: a flexible statistical power analysis program fort he social, behavioural, and biomedical sciences. Behav Res Method 39: 175-191.
21. Gauggel S, Rieger M, Feghoff TA. (2004). Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 75: 539-544.
22. Hedges LV, Olkin I. 1985. Statistical methods for meta-analysis. Academic Press: Orlando.
23. Hennig J, Kroeger A, Meyer B, Prochaska H, Krien P, Huwe S, Netter P. 1998. Personality correlates of ±pindolol induced decreases in prolactin. Pharmacopsychiatry 31: 19-24.
24. Kaernbach C. 1991. Simple adaptive testing with the weighted up down method. Percept Psychophys 49: 227-229.
25. Lader M, Melhuish A, Fricka G, Fredericson Overo K, Christensen V. 1986. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur J Clin Pharmacol 31: 183-190.
26. Lappin JS, Eriksen CW. 1966. Use of a delayed signal to stop a visual reaction-time response. J Exp Psychol 72: 805-811.
27. Lister S, Pearce JM, Butcher SP, Collard KJ, Foster GA. 1996. Acquisition of conditioned responses in rats is impaired by ablation of serotonergic pathways. Eur J Neurosci 8(2): 415-423.
28. Logan GD. 1983. On the ability to inhibit simple thoughts and actions: I. stop-signal studies o of decision and memory. J Exp Psychol: Hum Percept Perform 9: 585-606.
29. Logan GD, Burkell J. 1986. Dependence and independence in responding to double stimulation: a comparison of stop, change and dual-task paradigms. J Exp Psychol: Hum Percept Perform 12: 549-563.
30. Logan GD. On the ability to inhibit thought and action: a users' guide to ths stop-signal paradigm. In Dagenbach D, Carr TH (eds). Inhibitory Processes in Attention, Memory and Language. San Diego; Academic Press: 1994. p 189-239.
31. Logan GD, Cowan WB, Davis KA. 1984. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol: Hum Percept Perform 10(2): 276-291.
32. Luparini MR, Garrone B, Pazzagli M, Pinza M, Pepeu G. 2004. A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone. Prog Neuropsychopharmacol Biol Psychiatry 28(7): 1117-1127.
33. Masaki D, Yokoyama C, Kinoshita S, et al. 2006. Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology (Berl) 189: 249-258.
34. Marsh D, Dougherty D, Moeller F, Swann A, Spiga R. 2002. Laboratory-measured aggressive behaviour of women: acute tryptophan depletion and augmentation. Neuropsychopharmacology 26: 660-671.
35. Meeter M, Talamini L, Schmitt JA, Riedel WJ. 2006. Effects of 5-HT on memory and the hippocampus. Neuropsychopharmacology 31(4): 712-720.
36. Netter P, Hennig J, Rohrmann S. 1999. Psychobiological differences between aggression and psychoticism. Pharmacopsychiatry 32: 5-12.
37. Rieger M, Gauggel S, Burmeister K. 2003. Inhibition of ongoing responses following frontal, non-frontal and basla ganglia lesions. Neuropsychology 17: 272-282.
38. Robbins TW. 2000. From arousal to cognition: the integrative position of the prefrontal cortex. Prog Brain Res 126: 469-483.
39. Robbins TW. 2007. Shifting and Stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond Series B: Biol Sci 362: 917-932.
40. Rubia K, Overmeyer S, Taylor E, et al. 1999. Hypofrontality in Attention Deficit Hyperactivity Disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 156(6): 891-896.
41. Rubia K, Overmeyer S, Taylor E, et al. 2000. Functional frontalisation with age: mapping neurodevelopmental trajetories with fMRI. Neurosci Biobehav Rev 24: 13-19.
42. Rubia K, Russell T, Overmeyer S, et al. 2001. Mapping motor inhibition: conjunctive brain analysis across different versions of go/no-go and stop tasks. NeuroImage 13: 250-261.
43. Rubia K, Noorloos J, Smith A, Gunning B, Sergeant J. 2003. Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol 31(3): 301-313.
44. Schweighofer N, Bertin M, Shishida K, Okamoto Y, Tanaka SC, Yamawaki S, Doya K. 2008. Low-serotonin levels increase delayed reward discounting in humans. J Neurosci 28(17): 4528-4532.
45. Smith R. 1992. Inhibition: History and Meaning in the Science of Mind and Brain. University of California Press Berkeley, Califonia.
46. Søgaard B, Mengel H, Rao N, Larsen F. 2005. The pharmacokonetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. J Clin Pharmacol 45(12): 1400-1406.
47. Schmitt JAJ, Wingen M, Ramaekers JG, Evers EAT, Riedel WJ. 2006. Serotonin and human cognitive performance. Curr Pharm Des 12: 2473-2486.
48. Verbruggen F, Logan GD. 2008. Automatic and controlled response inhibition: the role of associative learning in the Go/Nogo and Stop-Signal paradigms. J Exp Psychol: Gen 137(4): 649-672.
49. Verbruggen F, Logan GD. 2009. Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev 33: 647-661.
50. Verbruggen F, Schneider DW, Logan GD. 2009. How to stop and change a response: the role of goal activation in multitasking. J Exp Psychol: Hum Percept Perform 34(5): 1212-1228.
51. Waugh J, Goa KL. 2003. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 17(5): 343-362.
52. Winstanley CA, Dalley JW, Theobald DE, Robbins TW. 2003. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl.) 170: 320-331.
53. Winstanley CA, Theobald DE, Dalley JW, Robbins TW. 2005. Interactions between serotonine and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacolgy 30(4): 669-682.